644: Matt Timmins of Fintel discusses their positive 2021 results & reasons for confidence in their outlook
643: Bill Brodie Good of Alien Metals discusses a further 3km of new high-grade ridge targets at Hancock Iron Ore Project
642: Jeremy Skillington of Poolbeg Pharma discusses the clinical trial agreement for POLB 001 human challenge study
641: 5 Things You Need To Know, Today, on Thursday 31st March 2022
640: Harvey Sinclair of eEnergy discusses the launch of eCharge to create the UK's largest public sector charging network
639: Kiran Morzaria of Cadence explains the benefits of selling their stakes in Lithium Technologies & Lithium Supplies
638: 5 Things You Need To Know, Today, on Wedesday 30th March 2022
637: Andrew Knott of Savannah Energy discusses the agreement with Niger Government for the country's first wind farm
636: Alasdair Haynes of Aquis Exchange discusses their final results which saw revenue up 42% to £16.2 million
635: 5 Things You Need To Know, Today, on Tuesday 29th March 2022
634: Neil Clark & Shaun Claydon of Destiny Pharma: Funds raised will be used to accelerate the development of their two lead key assets
633: James van den Bergh of Trufin explains the significance of Satago’s agreement with Lloyds Bank
632: 5 Things You Need To Know, Today, on Monday 28th March 2022
631: Mo Khan of Open Orphan discusses their £5m RSV human challenge study contract win
630: 5 Things You Need To Know, Today, on Friday 25th March 2022
629: Eytan Uliel of Challenger Energy explains how their activity is focused on building production and generating cash flow
628: Jeremy Skillington of Poolbeg Pharma discusses their deal with CytoReason, a leading AI company
627: 5 Things You Need To Know, Today, on Thursday 24th March 2022
626: Tim Ward of the QCA: How can retail investors get better access to equity fundraises, IPO's & research?
625: 5 Things You Need To Know, Today, on Wednesday 23rd March 2022
624: Bill Brodie Good of Alien Metals explains the benefits behind the acquisition of the Munni Munni Platinum Group Metals and Gold Project
623: Bobby Kalar of Yu Group: We’ve delivered on our promise to generate profitable growth, which is set to continue
622: Andrew Bell of Red Rock Resources discusses second batch of assay results from the Mikei Gold Project
621: 5 Things You Need To Know, Today, on Tuesday 22nd March 2022
620: George Frangeskides of Alba: Assay results return gold grades of up to 11.35 g/t at Clogau-St David's Gold Mine
619: 5 Things You Need To Know, Today, on Monday 21st March 2022
618: Paul Hill discusses the recent rate rise rally and some stocks to follow
617: Thor Johnsen explains how they aim to deliver sustainable income & capital growth with Digital 9 Infrastructure
615: 5 Things You Need To Know, Today, on Friday 18th March 2022
614: Kirk Adams of GreenRoc Mining discusses the progress of their graphite projects in Greenland
613: Christian Taylor-Wilkinson of Altona Rare Earths: Phase 2 drilling campaign to proceed after positive results from Phase 1 at Monte Muambe
612: John Clarke of Gfinity explains how the funds raised will help them achieve more growth & profitability
611: 5 Things You Need To Know, Today, on Thursday 17th March 2022
610: Sara Barrington of Verici Dx explains their how recent funds raised will accelerate the commercialisation of lead products
609: Harvey Sinclair, CEO of eEnergy: Robust progress in H1 and strong momentum with forward contracted revenue up by 205%
608: 5 Things You Need To Know, Today, on Wednesday 16th March 2022
607: Craig Martin of Vietnam Holding explains how the fund is largely uncorrelated to macro issues
606: 5 Things You Need To Know, Today, on Tuesday 15th March 2022
605: 5 Things You Need To Know, Today, on Monday 14th March 2022
604: The Vox Markets Podcast: Nicholas Lee, Director, Pires Investments
603: 5 Things You Need To Know, Today, on Friday 11th March 2022
602: Eytan Uliel of Challenger Energy discusses the restructuring, new appointment and news flow expected
601: Andrew Bell of Red Rock provides a general update and commentary on commodity prices
600: 5 Things You Need To Know, Today, on Wednesday 10th March 2022
599: Tim Ward of the Quoted Companies Alliance discusses the importance of the retail investor for small & mid cap companies
598: Neil Clark & Shaun Claydon of Destiny Pharma: new funds will progress two lead clinical assets towards Phase 3 trials
597: John Clarke of Gfinity discusses their trading update and reiterates pathway to profitability in 2023
596: Cathal Friel & Mo Khan of Open Orphan expect 2021 to be EBITDA positive on revenues of £40m
595: 5 Things You Need To Know, Today, on Wednesday 9th March 2022
594: Kirk Adams of GreenRoc discusses their significant maiden ore graphite resource in Greenland
next page